Clinical-Scale Cultures of Cord Blood CD34+ Cells to Amplify Committed Progenitors and Maintain Stem Cell Activity
- 1 October 2011
- journal article
- research article
- Published by SAGE Publications in Cell Transplantation
- Vol. 20 (9) , 1453-1464
Abstract
We developed a clinical-scale cord blood (CB) cell ex vivo procedure to enable an extensive expansion of committed progenitors—colony-forming cells (CFCs) without impairing very primitive hematopoietic stem cells (HSCs). CD34++ cells, selected from previously cryopreserved and thawed CB units, were cultured in two steps (diluted 1:4 after 6 days) in the presence of stem cell factor (SCF), fms-related tyrosine kinase 3 ligand (Flt-3L), megakaryocyte growth and development factor (MGDF) (100 ng/ml each), granulocyte-colony stimulating factor (G-CSF) (10 ng/ml) in HP01 serum-free medium. HSC activity was evaluated in a serial transplantation assay, by detection of human cells (CD45, CD33, CD19 and CFC of human origin) in bone marrow (BM) of primary and secondary recipient NOD/SCID mice 6–8 weeks after transplantation. A wide amplification of total cells (~350-fold), CD34+ cells (~100-fold), and CFC (~130-fold) without impairing the HSC activity was obtained. The activity of a particular HSC subpopulation (SRCCFC) was even enhanced. Thus, an extensive ex vivo expansion of CFCs is feasible without impairing the activity of HSCs. This result was enabled by associating antioxidant power of medium with an appropriate cytokine cocktail (i.e., mimicking physiologic effects of a weak oxygenation in hematopoietic environment).Keywords
This publication has 28 references indexed in Scilit:
- Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitutionNature Medicine, 2010
- Ex Vivo Nanofiber Expansion and Genetic Modification of Human Cord Blood-Derived Progenitor/Stem Cells Enhances VasculogenesisCell Transplantation, 2009
- Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trialBone Marrow Transplantation, 2008
- Ex Vivo Expansion and Transplantation of Hematopoietic Stem/Progenitor Cells Supported by Mesenchymal Stem Cells from Human Umbilical Cord BloodCell Transplantation, 2007
- Large‐scale expansion and transplantation of CD34+ hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long‐term engraftment capacityTransfusion, 2006
- Very Low O2 Concentration (0.1%) Favors G0 Return of Dividing CD34+ CellsStem Cells, 2006
- Cord Blood Processing by Using a Standard Manual Technique and Automated Closed System "Sepax" (Kit CS-530)Stem Cells and Development, 2005
- An Efficient Large-Scale Thawing Procedure for Cord Blood Cells Destined for Selection and Ex Vivo Expansion of CD34 + CellsJournal of Hematotherapy & Stem Cell Research, 2003
- Distinct classes of human stem cells that differ in proliferative and self-renewal potentialNature Immunology, 2001
- Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitroBlood, 2000